What is the Impact Factor of Neuromodulation?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Neuromodulation is 3.70, ranking in quartile Q2 of Web of Science (SCIE).

Is Neuromodulation indexed in Web of Science or Scopus?

Yes, Neuromodulation is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.076 (Q1) and an H-index of 86.

Who publishes Neuromodulation and what is the Article Processing Charge (APC)?

Neuromodulation is published by Wiley-Blackwell Publishing Ltd. The estimated Article Processing Charge (APC) is approximately $3,289 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Neuromodulation?

The official ISO-4 abbreviation of Neuromodulation is "NEUROMODULATION" with common acronym "ner". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #4,342Hybrid

Neuromodulation

Acronym:ner

•

Abbreviation (ISO):NEUROMODULATION

•

Identifier (ISSN):1094-7159(Print)/1525-1403(Online)

•

Publisher:Wiley-Blackwell Publishing Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

3.7↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Neuromodulation

WoS Q2

Annual Impact Factor Metric

Current (2026):3.7

Scopus SJR & RankScopus Q1

1.076

#4,342

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

86 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate12.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

160articles/year

29.93% Gold OA•78.26% Original Research

Aims & Scope

Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with the state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists and members of the biotechnology industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease and improve function.

Topics Covered (Recognized by AI)

Medicine99.8%Biology80.9%Internal medicine79.1%Psychology78.3%Neuroscience73.2%Endocrinology63.6%Stimulation59.3%Psychiatry56.6%Anesthesia48.9%Surgery48.7%Pathology44.2%Chemistry34%Physical therapy32.5%Genetics31.7%Biochemistry31.1%Spinal cord27.4%Receptor26.6%Radiology22.1%Physics22.1%Central nervous system21.1%Pharmacology20.4%Anatomy20.2%

Primary Research Areas

Medicine Clinical Neurology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CLINICAL NEUROLOGY

Rank85/296

IndexSCIE

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank75/191

IndexSCIE

JCRSCIE2026

NEUROSCIENCES

Rank126/330

IndexSCIE

JCISCIE2026

CLINICAL NEUROLOGY

Rank67/296

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank47/191

IndexSCIE

JCISCIE2026

NEUROSCIENCES

Rank85/330

IndexSCIE

Category	Index	Rank	Quartile
CLINICAL NEUROLOGY	JCRSCIE	85/296	Q2
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	75/191	Q2
NEUROSCIENCES	JCRSCIE	126/330	Q2
CLINICAL NEUROLOGY	JCISCIE	67/296	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	47/191	Q1
NEUROSCIENCES	JCISCIE	85/330	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.7

Articles / Year544

Total Citations37

2025

IF3.5

Articles / Year1,131

Total Citations381

2024

IF3.2

Articles / Year649

Total Citations962

2023

IF2.8

Articles / Year888

Total Citations1,540

2022

IF3.025

Articles / Year982

Total Citations3,200

Year	Impact Factor	Articles / Year	Total Citations
2026	3.7	544	37
2025	3.5	1,131	381
2024	3.2	649	962
2023	2.8	888	1,540
2022	3.025	982	3,200
2021	4.722	213	2,987
2020	4.029	252	4,417
2019	2.663	188	3,270
2018	2.774	176	3,588
2017	—	202	7,231
2016	—	148	4,197
2015	—	121	3,772

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,342Scopus Q1SCImago Profile

Scopus Coverage:1998-2026

•

Scopus Broad Areas:MedicineNeuroscience

Scopus Citation Rank (SJR)Q1

1.076

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.31

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,289 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,961

3-Year Documents532

Citable Documents491

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate36.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Anesthesiology and Pain MedicineQ1

Medicine (miscellaneous)Q1

NeurologyQ1

Neurology (clinical)Q1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 12.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区MEDICINE, RESEARCH & EXPERIMENTAL

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neuromodulation (acronym: ner, abbr: NEUROMODULATION, ISSN: 1094-7159) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in United States since 1998. The periodical holds a Journal Impact Factor (JIF) of 3.70, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.076 (Q1), an H-index of 86.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 160 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,289 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.